BioLife Solutions (BLFS) PT Raised to $64 at Cowen
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $19.86 -1.29%
Rating Summary:
15 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
15 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Cowen analyst Chris Lin raised the price target on BioLife Solutions (NASDAQ: BLFS) to $64.00 (from $50.00) while maintaining an Outperform rating.
The analyst commented, "BLFS delivered a healthy Q2 beat versus Street expectations, driven by strong organic growth (+49% Y/Y) and nearly +200 new customers wins (compared to +80 in Q1 and +213 in FY'20). BLFS lifted its F2021 revenue guidance by +$2M to reflect its recent acquisition of Sexton Biotechnologies, which leaves potential room for a beat-and-raise in Q3, in our view. Outperform; PT to $64."
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Cowen & Co, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
